# Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides

> **NCT05322005** · NA · COMPLETED · sponsor: **Mastelli S.r.l** · enrollment: 60 (actual)

## Conditions studied

- Meniscus Tear
- Meniscus Lesion

## Interventions

- **PROCEDURE:** partial meniscectomy
- **DEVICE:** Condrotide® (polynucleotides gel: class III medical device)

## Key facts

- **NCT ID:** NCT05322005
- **Lead sponsor:** Mastelli S.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2024-07-27
- **Final completion:** 2024-07-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322005, "Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05322005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*